Detalles de la búsqueda
1.
Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance.
Mol Cancer Ther
; 17(2): 521-531, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158469
2.
Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.
J Immunol Methods
; 318(1-2): 65-74, 2007 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17126853
3.
Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation.
Mol Cancer Ther
; 4(11): 1801-9, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16276002
4.
Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.
Neoplasia
; 13(1): 49-59, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21245940
5.
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.
Neoplasia
; 11(6): 594-604, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19484148
6.
An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.
Biochem Biophys Res Commun
; 357(4): 1142-7, 2007 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17462601
7.
Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
J Biol Chem
; 281(16): 10706-14, 2006 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-16481314
Resultados
1 -
7
de 7
1
Próxima >
>>